KT
Karyopharm Therapeutics Inc
🇺🇸XNAS.KPTIUnited StatesHealthcare
$1.63USDup +0.03 (+1.88%)OpenEnd of day3:30 PM
Price$1.63+0.03 (+1.88%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US48576U2050
- CUSIP
- 48576U106
Company
- Employees
- 228
- Headquarters
- Newton, United States
- Website
- https://www.karyopharm.com
- CEO
- Mr. Richard A. Paulson M.B.A.
Market
- Shares outstanding
- 22.7M
- Market cap
- $36.97M
Key dates
- Next earnings
- Nov 2, 2026
Highlights
- Market cap
- $36.97M
- EPS LTM
- -$9.91calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.16calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $146.62M+6.81%up year on year
- Net income
- -$224.74M-81.88%down year on year
- Gross margin
- 95.88%-0.51%down year on year
- Free cash flow
- -$65.35M+36.49%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.